Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSupply@me Cap Regulatory News (SYME)

Share Price Information for Supply@me Cap (SYME)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.025
Bid: 0.024
Ask: 0.027
Change: 0.0005 (2.00%)
Spread: 0.003 (12.50%)
Open: 0.026
High: 0.03
Low: 0.025
Prev. Close: 0.025
SYME Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of Prospectus & Total Voting Rights

3 Oct 2022 12:22

RNS Number : 5814B
Supply @ME Capital PLC
03 October 2022
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM ANY JURISDICTION WHERE SUCH DISTRIBUTION WOULD BE UNLAWFUL.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU, WHICH IS PART OF UNITED KINGDOM DOMESTIC LAW PURSUANT TO THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS (SI 2019/310) ("UK MAR"). UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION (AS DEFINED IN UK MAR) IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

This announcement is an advertisement for the purposes of the Prospectus Regulation Rules of the FCA and is not a prospectus nor an offer of securities for sale in any jurisdiction.

Neither this announcement, nor anything contained herein shall form the basis of, or be relied upon in connection with, any offer or commitment whatsoever in any jurisdiction. Investors should not subscribe for or purchase any securities referred to in this announcement except solely on the basis of the information contained in the prospectus referred to in this announcement (together with any supplementary prospectus, if relevant, the "Prospectus"), including the risk factors set out therein, published by Supply@ME Capital plc (the "Company" or "SYME").

Words and expressions defined in the Prospectus shall, unless the context provides otherwise, have the same meanings in this announcement.

An electronic copy of the Prospectus dated 3 October 2022 will shortly be available for inspection on the Company's website at https://www.supplymecapital.com/investor/ and will be submitted to the National Storage Mechanism maintained by the FCA and will be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

3 October 2022

Supply@ME Capital plc

Publication of Prospectus

Admission of Admission Shares

Secondary Admission of Secondary Admission Shares

Further Admission of Further Admission Shares

Entry into Side Letter with Venus to raise Venus Amount

Entry into Addendum Deed with Mercator containing Mercator Repayment Option

Total Voting Rights

SYME, the fintech business which provides an innovative fintech platform ("Platform") for use by manufacturing and trading companies to access Inventory Monetisation© solutions enabling their businesses to generate cashflow, is pleased to announce publication of the Prospectus prepared in relation to, inter alia:

· Admission of Admission Shares, comprising 3,048,986,302 Ordinary Shares issued to Venus on conversion of £1,500,000 Tranche B Venus CLNs plus accrued interest;

· Secondary Admission of Secondary Admission Shares, comprising all remaining 1,230,000,000 Venus Mandatory Subscription Shares, all remaining 7,500,000,000 Venus Optional Subscription Shares and 848,498,083 Ordinary Shares issued to Venus on conversion of £417,500 Tranche A Venus CLNs plus accrued interest;

· the entry by the Company and Venus into the Side Letter, pursuant to which the Company has contractually agreed to raise the Venus Amount (£4,365,000 in aggregate), and be in receipt of immediately available funds to exercise and settle the Mercator Exercise Option on or before 17 October 2022;

· the entry by the Company, Supply@ME Italy and Mercator into the Addendum Deed, pursuant to which the Company has secured the Mercator Repayment Option to pay, at its discretion at any time prior to or on 17 October 2022, £3,536,553 in cash in immediately available funds to Mercator in full and final settlement of all outstanding amounts payable under the Mercator Loan Notes and the Mercator CLNs (including incurred fees), and, if such amount is paid by the Company, the Company will not be required to issue any additional Mercator Conversion Shares; and

· assuming the exercise by the Company of the Mercator Repayment Option utilising the Venus Amount and following any relevant conversion or exercise event(s) from time to time, Further Admission of up to a maximum of 9,442,956,647 Further Admission Shares, comprising up to 961,832,433 Mercator Warrant Shares, up to 8,175,000,000 Venus Warrant Shares and up to 306,124,214 Open Offer Warrant Shares.

Alessandro Zamboni, CEO of SYME, said:

"The publication of the Prospectus is an important step in the Capital Enhancement Plan, announced on 27 April 2022, which seeks to settle the Company's existing debts and procure further financing on terms more favourable to SYME and our Shareholders.

"Under the Capital Enhancement Plan, the Company entered into the Mercator Amendment and the Venus Subscription Agreement and undertook the Open Offer in order to raise up to £7,500,000 in new equity capital to enable the Company, at its election, to settle the outstanding Mercator Loan Notes and Mercator CLNs in cash rather than by the conversion of Mercator CLNs into Mercator Conversion Shares.

"Pursuant to the Side Letter and the Addendum Deed, both executed today, the Company has agreed with Venus and Mercator (respectively) to, inter alia, accelerate Venus's subscription of all remaining Venus Mandatory Subscription Shares and Venus Optional Subscription Shares at Secondary Admission to raise gross proceeds of £4,365,000 (i.e., the Venus Amount).

"It is the intention of the Company to exercise the Mercator Repayment Option and to pay £3,536,553to Mercator in full and final settlement of all outstanding amounts payable by the Company to Mercator under the Mercator Loan Notes and Mercator CLNs (including incurred fees) utilising the Venus Amount.

"Given the inherent protective optionality baked into the Mercator Repayment Option, for good order, the Company has set out in the Part IV of the Prospectus the estimated maximum numbers of New Ordinary Shares which it would need to issue in the context of Further Admission in the scenario where it does and does not trigger the Mercator Repayment Option. Clearly, the Company's stated intention is to exercise the Mercator Repayment Option after Secondary Admission takes place and once it is in receipt of the Venus Amount - investors are strongly encouraged to bear that in mind.

"The Board firmly believes that following Admission, Secondary Admission and the exercise of the Mercator Repayment Option utilising the Venus Amount, the "cap table" of the Company will be rationalised and, when taken with the first Inventory Monetisation© transaction, the investment proposition of SYME is significantly de-risked and its equity story is advanced. Moreover, the Company does not expect to raise additional finance through the issue of further new Ordinary Shares in the foreseeable future, save, of course, to the extent any outstanding warrants are exercised by existing holders."

The Company has made applications to the FCA and the London Stock Exchange in connection with Admission, which is expected to occur at 8.00 a.m. on 6 October 2022.

The Company hereby notifies the market, in accordance with the FCA's Disclosure Guidance and Transparency Rule 5.6.1, that on Admission, the Company's issued share capital will consist of 47,008,292,650 Ordinary Shares, each with one vote. The Company does not hold any Ordinary Shares in treasury. On Admission, the total number of voting rights in the Company will be 47,008,292,650 and this figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

The Company will make applications to the FCA and the London Stock Exchange in connection with Secondary Admission, which is expected to occur on 11 October 2022.

Further Admission of any Further Admission Shares will become effective, and unconditional dealings in such Further Admission Shares will commence, on a date (or dates) to be determined following the relevant conversion or exercise event(s) from time to time.

The Company will notify the market of the total voting rights denominator to be used by Shareholders following Secondary Admission and Further Admission(s) in due course. 

For the purposes of UK MAR, the person responsible for arranging release of this announcement on behalf of SYME is Alessandro Zamboni, CEO.

Enquiries

Investors & analysts:

Alessandro Zamboni, CEO, Supply@ME Capital plc, investors@supplymecapital.com

Paul Vann, Walbrook PR Limited, +44 (0)20 7933 8780; paul.vann@walbrookpr.com

Media:

Nicole Louis, MHP, Nicole.Louis@mhpc.com

Orrick, Herrington & Sutcliffe (UK) LLP is acting as legal adviser to SYME.

Notes

SYME and its operating subsidiaries provide a Platform for use by manufacturing and trading companies to access inventory trade solutions enabling their businesses to generate cashflow, via a non-credit approach and without incurring debt. This is achieved by their existing eligible inventory being added to the Platform and then monetised via purchase by third party Inventory Funders. The inventory to be monetised can include warehouse goods waiting to be sold to end-customers or goods/commodities that are part of a typical import/export transaction. SYME announced in August 2021 the launch of a global Inventory Monetisation programme which will be focused on both inventory in transit monetisation and warehouse goods monetisation. This program will be focused on creditworthy companies and not those in distress or otherwise seeking to monetise illiquid inventories. 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PDIFXLFBLBLLFBB
Date   Source Headline
5th Apr 20247:00 amRNSBusiness update
4th Apr 20247:00 amRNSDirector/PDMR Shareholding
28th Mar 20247:00 amRNSTransfer of Warrants
27th Mar 20247:00 amRNSTransaction of a Person Closely Associated
22nd Mar 20247:00 amRNSPDMR/PCA shareholding: stock loans update
29th Feb 20247:00 amRNSBusiness, trading and funding update
19th Feb 20247:00 amRNSExercise of warrants, issue of equity and TVR
26th Jan 20247:00 amRNSHolding(s) in Company
11th Jan 20247:00 amRNSExercise of warrants, issue of equity and TVR
3rd Jan 20247:00 amRNSWhite-Label IM Agreement - funding secured
5th Dec 20238:40 amRNSFunding and Business update
23rd Nov 20237:00 amRNSTransfer of Warrants
6th Nov 20237:00 amRNSExercise of Warrants, issue of equity and TVR
1st Nov 20238:58 amRNSTotal Voting Rights
10th Oct 20237:00 amRNSExercise of Warrants, issue of equity and TVR
29th Sep 20237:00 amRNSHalf-year Report
25th Sep 20237:00 amRNSExercise of Warrants, issue of equity and TVR
12th Sep 20237:00 amRNSExercise of Open Offer Warrants
1st Sep 20237:00 amRNSTotal Voting Rights
17th Aug 20237:00 amRNSExercise of options, issue of equity and TVR
4th Aug 202312:34 pmRNSHolding(s) in Company
2nd Aug 20237:00 amRNSTotal Voting Rights
7th Jul 20237:00 amRNSDirector/PDMR Shareholding
5th Jul 20237:00 amRNSExercise of Warrants, issue of equity and TVR
3rd Jul 20237:00 amRNSExecution of first UK IM using traditional funding
30th Jun 20235:36 pmRNSHolding(s) in Company
30th Jun 202312:54 pmRNSTotal Voting Rights
30th Jun 20237:00 amRNSTransaction of a Person Closely Associated
23rd Jun 20235:37 pmRNSResult of General Meeting
23rd Jun 20235:36 pmRNSResult of AGM
15th Jun 202311:00 amRNSReplacement Total Voting Rights
15th Jun 20238:00 amRNSNew Italian PNP regulation comes into effect
13th Jun 20237:00 amRNSExercise of Warrants, issue of equity and TVR
9th Jun 20237:00 amRNSFirst UK IM transaction from traditional funding
5th Jun 20237:00 amRNSExercise of Warrants, Issue of Equity and TVR
2nd Jun 202312:51 pmRNSHolding in Company
31st May 20233:56 pmRNSNotice of GM of Open Offer Warrantholders
31st May 20233:55 pmRNSNotice of Annual General Meeting
26th May 20237:00 amRNSAdmission of Shares and Total Voting Rights
23rd May 20237:00 amRNSExercise of Warrants, Issue of Equity and TVR
22nd May 20237:00 amRNSGrant of Awards under the Supply@ME LTIP
19th May 20231:40 pmRNSHolding(s) in Company
16th May 20237:00 amRNSInvestor Presentation via Investor Meet Company
9th May 20233:03 pmRNSHolding(s) in Company
5th May 20237:00 amRNSExecution of first IM from traditional funding
4th May 202312:40 pmRNSAdmission and Exercise of Open Offer Warrants
2nd May 202312:00 pmRNSSYME moves to SETS trading platform
28th Apr 20232:51 pmRNS2022 Annual Report and Accounts and Financing
26th Apr 20237:00 amRNSCommitment for first IM from traditional funding
13th Apr 202310:59 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.